LysoPC(22:5)
|
Basic information |
| Metabolite name | LysoPC(22:5) |
 | N/A |
 |
C04230 |
 |
N/A |
| Synonyms | LysoPC(22:5) |
| No. of studies | 7 |
|
Basic information |
| Metabolite name | LysoPC(22:5) |
| N/A |
|
C04230 |
|
N/A |
| Synonyms | LysoPC(22:5) |
| No. of studies | 7 |
|
Relationship between LysoPC(22:5) and depression (count: 7) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1024 | Type1 | CUMS group vs. control group | Serum | ICR mouse | Down |
| Study M1024 | Type2 | CUMS + hydroxytyrosol group vs. CUMS group | Serum | ICR mouse | Up |
| Study M1117 | Type1 | MDD group vs. control group, Chinese cohort | Plasma | Human | Up |
| Study M457 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Up |
| Study M512 | Type1 | CUMS group vs. control group | Plasma | Goto-Kakizaki rat | Down |
| Study M540 | Type1 | CUMS group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M613 | Type1 | CSDS susceptible group vs. control group | Serum | C57BL/6 J mouse | Up |
| Study M880 | Type1 | depression group vs. control group | Plasma | Cynomolgus monkey | Down |